CIK: 0001848809 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $174,553 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALIMERA SCIENCES INC | 13,608,533 | $75,663 | 43.3% | $3.12 | — | COM NEW | 016259202 |
| JSPR | JASPER THERAPEUTICS INC | 1,471,904 | $32,548 | 18.6% | $17.76 | +35.0% | COM NEW | 471871202 |
| HRTX | HERON THERAPEUTICS INC | 6,986,744 | $24,454 | 14.0% | $2.38 | +29.3% | COM | 427746102 |
| PRAX | PRAXIS PRECISION MEDICINES I | 350,666 | $14,504 | 8.3% | $18.39 | +156.9% | COM NEW | 74006W207 |
| — | TOURMALINE BIO INC | 319,080 | $4,103 | 2.4% | $26.18 | — | COM | 89157D105 |
| TELA | TELA BIO INC | 746,087 | $3,507 | 2.0% | $7.03 | -25.1% | COM | 872381108 |
| RZLT | REZOLUTE INC | 800,000 | $3,440 | 2.0% | $2.43 | +41.4% | COM NEW | 76200L309 |
| SKYE | SKYE BIOSCIENCE INC | 422,142 | $3,381 | 1.9% | $11.84 | 0.0% | COM NEW | 83086J200 |
| — | OPTINOSE INC | 2,492,830 | $2,593 | 1.5% | $2.21 | — | COM | 68404V100 |
| CNTX | CONTEXT THERAPEUTICS INC | 1,290,323 | $2,587 | 1.5% | $1.72 | 0.0% | COM | 21077P108 |
| NSPR | INSPIREMD INC | 904,029 | $2,256 | 1.3% | $1.59 | +47.2% | COM | 45779A846 |
| OTLK | OUTLOOK THERAPEUTICS INC | 247,084 | $1,823 | 1.0% | $8.09 | -0.7% | COM | 69012T305 |
| — | ELEVATION ONCOLOGY INC | 597,299 | $1,613 | 0.9% | $1.72 | — | COM | 28623U101 |
| TARA | PROTARA THERAPEUTICS INC | 480,000 | $998 | 0.6% | $2.92 | 0.0% | COM STK | 74365U107 |
| KPRX | KIORA PHARMACEUTICALS INC | 122,223 | $513 | 0.3% | $4.67 | 0.0% | COM | 49721T507 |
| — | X4 PHARMACEUTICALS INC | 659,020 | $382 | 0.2% | $0.58 | — | COM | 98420X103 |
| — | ASLAN PHARMACEUTICALS LTD | 625,000 | $188 | 0.1% | $0.62 | — | SPON ADS NEW | 04522R200 |